| __timestamp | Ligand Pharmaceuticals Incorporated | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 1162636000 |
| Thursday, January 1, 2015 | 66107000 | 1396725000 |
| Friday, January 1, 2016 | 103402000 | 1526100000 |
| Sunday, January 1, 2017 | 135736000 | 1619600000 |
| Monday, January 1, 2018 | 245116000 | 1429100000 |
| Tuesday, January 1, 2019 | 108935000 | 1331200000 |
| Wednesday, January 1, 2020 | 156000000 | 1375200000 |
| Friday, January 1, 2021 | 214957000 | 1563000000 |
| Saturday, January 1, 2022 | 143418000 | 1789600000 |
| Sunday, January 1, 2023 | 96265000 | 2070000000 |
Cracking the code
In the competitive landscape of biotechnology, United Therapeutics Corporation and Ligand Pharmaceuticals Incorporated have showcased distinct trajectories in their gross profit performance over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed Ligand Pharmaceuticals, with gross profits peaking at approximately $2.07 billion in 2023, marking a substantial growth of nearly 78% from 2014. In contrast, Ligand Pharmaceuticals experienced a more volatile journey, with gross profits reaching their zenith in 2018 at around $245 million, before declining to about $96 million in 2023. This divergence highlights United Therapeutics' robust growth strategy and market positioning, while Ligand Pharmaceuticals navigates a more fluctuating path. As the biotech industry continues to evolve, these companies' financial narratives offer valuable insights into strategic resilience and adaptability.
Gross Profit Trends Compared: Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Gross Profit Comparison: Incyte Corporation and Ligand Pharmaceuticals Incorporated Trends
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Alkermes plc vs Ligand Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.